Trial Profile
Effect of nintedanib on pulmonary hypertension in patients with idiopathic pulmonary fibrosis: A prospective cohort study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Jul 2018
Price :
$35
*
At a glance
- Drugs Nintedanib (Primary)
- Indications Idiopathic pulmonary fibrosis
- Focus Therapeutic Use
- 06 Jul 2018 New trial record
- 23 May 2018 Results presented at the 114th International Conference of the American Thoracic Society